Ventas, Inc. $VTR Shares Sold by GRS Advisors LLC

GRS Advisors LLC decreased its position in Ventas, Inc. (NYSE:VTR) by 93.8% during the third quarter, Holdings Channel reports. The firm owned 37,287 shares of the real estate investment trust’s stock after selling 560,541 shares during the quarter. Ventas comprises 0.2% of GRS Advisors LLC’s portfolio, making the stock its 25th largest holding. GRS Advisors LLC’s holdings in Ventas were worth $2,610,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. BI Asset Management Fondsmaeglerselskab A S boosted its holdings in Ventas by 97.7% during the 3rd quarter. BI Asset Management Fondsmaeglerselskab A S now owns 36,713 shares of the real estate investment trust’s stock valued at $2,570,000 after acquiring an additional 18,146 shares during the period. Investment Management Corp of Ontario increased its stake in Ventas by 1,019.0% during the second quarter. Investment Management Corp of Ontario now owns 133,061 shares of the real estate investment trust’s stock worth $8,403,000 after purchasing an additional 121,170 shares during the period. Hudson Bay Capital Management LP purchased a new stake in Ventas during the second quarter worth about $17,568,000. Aberdeen Group plc lifted its position in shares of Ventas by 8.3% during the third quarter. Aberdeen Group plc now owns 1,580,923 shares of the real estate investment trust’s stock worth $109,985,000 after purchasing an additional 120,825 shares in the last quarter. Finally, SCS Capital Management LLC acquired a new stake in shares of Ventas during the second quarter worth about $13,788,000. 94.18% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on VTR shares. Citigroup lifted their price objective on shares of Ventas from $88.00 to $96.00 and gave the company a “buy” rating in a report on Wednesday, February 11th. Royal Bank Of Canada increased their target price on shares of Ventas from $83.00 to $91.00 and gave the stock an “outperform” rating in a report on Tuesday, February 10th. Mizuho raised their price target on shares of Ventas from $87.00 to $94.00 and gave the company an “outperform” rating in a research report on Wednesday, March 4th. UBS Group restated a “neutral” rating and issued a $85.00 price target on shares of Ventas in a research note on Monday, February 9th. Finally, Weiss Ratings raised Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $89.00.

Insiders Place Their Bets

In other news, CEO Debra A. Cafaro sold 10,322 shares of the company’s stock in a transaction dated Monday, February 2nd. The stock was sold at an average price of $77.66, for a total transaction of $801,606.52. Following the completion of the transaction, the chief executive officer directly owned 1,114,034 shares of the company’s stock, valued at approximately $86,515,880.44. This represents a 0.92% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Robert F. Probst sold 29,930 shares of the stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $77.25, for a total value of $2,312,092.50. Following the completion of the transaction, the chief financial officer owned 138,434 shares in the company, valued at approximately $10,694,026.50. The trade was a 17.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 86,106 shares of company stock valued at $6,931,397 in the last ninety days. Insiders own 0.80% of the company’s stock.

Ventas Trading Up 0.6%

Shares of NYSE:VTR opened at $86.68 on Friday. Ventas, Inc. has a 52 week low of $60.15 and a 52 week high of $87.87. The company’s 50 day moving average is $81.46 and its two-hundred day moving average is $76.33. The company has a market cap of $41.17 billion, a PE ratio of 160.52, a P/E/G ratio of 2.10 and a beta of 0.73. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.03.

Ventas (NYSE:VTR) last released its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.89 by ($0.74). The firm had revenue of ($1,229.71) million for the quarter, compared to analysts’ expectations of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.Ventas’s revenue for the quarter was up 21.7% on a year-over-year basis. During the same period last year, the firm posted $0.81 earnings per share. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Equities analysts predict that Ventas, Inc. will post 3.4 earnings per share for the current fiscal year.

Ventas Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.52 per share. This is a positive change from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. Ventas’s dividend payout ratio (DPR) is presently 355.56%.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.